Annovis Bio (ANVS) announced the appointment of Mark Guerin, CPA, CMA, CFM, as Chief Financial Officer, CFO. Prior to joining Onconova, Guerin worked as an interim senior finance and accounting executive, facilitating post-acquisition integration activities of newly acquired private equity portfolio companies
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANVS:
- Annovis Bio announces publication of new article in Biomolecules on buntanetap
- Annovis Bio’s Promising Alzheimer’s Study: What Investors Need to Know
- Annovis Bio price target lowered to $10 from $12 at H.C. Wainwright
- Annovis Bio Reports Q2 2025 Progress and Financials
- Annovis Bio’s Promising Alzheimer’s Drug Trial: What Investors Need to Know